Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. (nature.com)

Authors: Gonzalez-Kozlova E … Gnjatic S Journal: Nature Medicine Published: 2026-03-01 DOI: https://doi.org/10.1038/s41591-025-04177-6